{"id":15737,"date":"2021-01-05T01:24:10","date_gmt":"2021-01-04T22:24:10","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/hiv-ile-infekte-hastalarda-standard-doz-hepatit-b-asisina-karsi-antikor-yaniti\/"},"modified":"2021-01-05T01:24:10","modified_gmt":"2021-01-04T22:24:10","slug":"hiv-ile-infekte-hastalarda-standard-doz-hepatit-b-asisina-karsi-antikor-yaniti","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/tr\/2021\/01\/05\/hiv-ile-infekte-hastalarda-standard-doz-hepatit-b-asisina-karsi-antikor-yaniti\/","title":{"rendered":"HIV ile \u0130nfekte Hastalarda Standard Doz Hepatit B A\u015f\u0131s\u0131na Kar\u015f\u0131 Antikor Yan\u0131t\u0131"},"content":{"rendered":"<h1>\u00d6zet<\/h1>\n<p> <strong>Ama\u00e7<\/strong>: Bu \u00e7al\u0131\u015fman\u0131n amac\u0131 HIV\/AIDS hastalar\u0131nda standard doz hepatit B a\u015f\u0131s\u0131na kar\u015f\u0131 antikor yan\u0131t\u0131n\u0131n retrospektif olarak incelenmesi, antikor yan\u0131t\u0131 olan ve olmayanlar\u0131n demografik, klinik ve laboratuvar parametreler a\u00e7\u0131s\u0131ndan kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131d\u0131r.<\/p>\n<p> <strong>Y\u00f6ntemler<\/strong>: Bu \u00e7al\u0131\u015fmada, Ocak 2002 ve Nisan 2010 tarihleri aras\u0131nda \u0130stanbul E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Poliklini\u011fi\u2019nden HIV\/AIDS tan\u0131s\u0131yla izlenen t\u00fcm hastalar\u0131n hepatit B virusu infeksiyonu y\u00f6n\u00fcnden serolojik verileri retrospektif olarak tarand\u0131. HBsAg-pozitif ya da anti-HBs-pozitif olanlar d\u0131\u015f\u0131nda kalan ve 0, 1 ve 6. ayda olmak \u00fczere toplam 3 doz standard doz hepatit B a\u015f\u0131lar\u0131 yap\u0131lan HBsAg-negatif ve anti-HBs-negatif olgular\u0131n, a\u015f\u0131 sonras\u0131 minimum 1 ay ya da daha uzun s\u00fcre sonra bak\u0131lm\u0131\u015f anti-HBs d\u00fczeyleri incelendi.<\/p>\n<p> <strong>Bulgular<\/strong>: Serolojik verileri olan 112 hastadan seronegatif bulunarak hepatit B a\u015f\u0131s\u0131 uygulanm\u0131\u015f 56 hastan\u0131n 15 (%26.8)\u2019inde anti-HBs d\u00fczeyleri 10 m\u0130\u00dc\/ml&#39;nin \u00fczerindeydi. Antikor olu\u015fan ve olu\u015fmayan iki grup aras\u0131nda ya\u015f, cinsiyet, ek hastal\u0131k, alkol, madde, sigara kullan\u0131m\u0131, antiretroviral tedavi al\u0131p almama y\u00f6n\u00fcnden istatistiksel olarak anlaml\u0131 bir fark yoktu (p&gt;0.05). \u0130ki grup\u00a0 aras\u0131nda CD4 de\u011ferleri bak\u0131m\u0131ndan istatistiksel olarak anlaml\u0131 bir fark bulunmazken; antikor olu\u015fmayan olgular\u0131n HIV RNA d\u00fczeyleri istatistiksel olarak anlaml\u0131 derecede daha y\u00fcksekti (p&lt;0.05).<\/p>\n<p> <strong>Sonu\u00e7lar<\/strong>: HIV ile infekte olgularda a\u015f\u0131ya yan\u0131t oran\u0131 d\u00fc\u015f\u00fckt\u00fcr ve bu yan\u0131t\u0131 etkileyen en \u00f6nemli fakt\u00f6r HIV viral y\u00fck\u00fcd\u00fcr. HIV ile infekte olgularda hepatit B a\u015f\u0131s\u0131 yap\u0131ld\u0131ktan sonra antikor durumunun de\u011ferlendirilmesi ve a\u015f\u0131 sonras\u0131 antikor yan\u0131t\u0131 vermeyen hastalara rapel ya da daha y\u00fcksek dozda a\u015f\u0131 yap\u0131lmas\u0131n\u0131n d\u00fc\u015f\u00fcn\u00fclmesi gerekmektedir.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00d6zet Ama\u00e7: Bu \u00e7al\u0131\u015fman\u0131n amac\u0131 HIV\/AIDS hastalar\u0131nda standard doz hepatit B a\u015f\u0131s\u0131na kar\u015f\u0131 antikor yan\u0131t\u0131n\u0131n retrospektif olarak incelenmesi, antikor yan\u0131t\u0131 olan ve olmayanlar\u0131n demografik, klinik ve laboratuvar parametreler a\u00e7\u0131s\u0131ndan kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131d\u0131r. Y\u00f6ntemler: Bu \u00e7al\u0131\u015fmada, Ocak 2002 ve Nisan 2010 tarihleri aras\u0131nda \u0130stanbul E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Poliklini\u011fi\u2019nden HIV\/AIDS tan\u0131s\u0131yla izlenen t\u00fcm [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5129],"tags":[4362,4361,4359,3228],"class_list":["post-15737","post","type-post","status-publish","format-standard","hentry","category-ozgun-arastirma","tag-antikor-yaniti","tag-edinsel-immun-yetmezlik-sendromu","tag-hepatit-b-asilari","tag-hiv"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts\/15737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/comments?post=15737"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts\/15737\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/media?parent=15737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/categories?post=15737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/tags?post=15737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}